PDL BioPharma Inc. (PDLI) tumbled -5.47% or -0.14 to $2.42. It is close to 2.19 million shares traded, which is 110.78% compare to the average total volume 1.98 million. The market cap of PDLI is $366.97 million. The year to date change is -16.27%. The 52 week price range is from $2.15 to $3.55. Price of PDLI have changed -1.16% during last week. It have changed -7.25% over last month, -8.90% over last 3 months, -11.72% over last 6 months and 8.47% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PDLI is 2.83. It is 16.94% above current price. The 200-day Moving Averages for PDLI is 2.92. It is 20.66% above current price. The 52-week High is 3.55. It is 46.69% from the current price. The 52-week Low is 2.15. It is -11.16% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PDLI is 11.8 on 2018-05-31. Short % to float is 12.79%. There are some statistics of PDLI. It is has market cap $366.97 million. The share outstanding is 151.64 million. The average volume is 1.98 million. The revenue is 206.58M. It has 951.82M cash and 478.48M in debt. The gross profit is 196.50M. The percent of top 15 Institution holding is 75.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PDLI is 13.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PDLI is 8.99%.